MCM
BIO icon

Moore Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Moore Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,000
Closed -$15.1M – 661
2025
Q4 		$15.1M Sell
50,000
-5,000
-9% -$1.56M 0.31% 110
2025
Q3 		$15.4M Buy
+55,000
New +$15M 0.31% 102
2025
Q2 		– Sell
-10,000
Closed -$2.44M – 557
2025
Q1 		$2.44M Sell
10,000
-35,000
-78% -$10.5M 0.08% 246
2024
Q4 		$14.8M Hold
45,000
– – 0.28% 138
2024
Q3 		$15.1M Buy
+45,000
New +$14.3M 0.44% 106
2023
Q4 		– Sell
-12,500
Closed -$4.48M – 457
2023
Q3 		$4.48M Sell
12,500
-12,500
-50% -$4.82M 0.12% 177
2023
Q2 		$9.48M Buy
25,000
+23,900
+2,173% +$9.73M 0.23% 104
2023
Q1 		$527K Buy
+1,100
New +$515K 0.02% 312

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return